Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methylation study of the Paris system for reporting urinary (TPS) categories.
Pierconti F, Martini M, Cenci T, Fiorentino V, Sacco E, Bientinesi R, Pugliese D, Iacovelli R, Schinzari G, Larocca LM, Bassi PF. Pierconti F, et al. Among authors: schinzari g. J Clin Pathol. 2021 Feb;74(2):102-105. doi: 10.1136/jclinpath-2020-206633. Epub 2020 Jun 11. J Clin Pathol. 2021. PMID: 32527754
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Grimm MO, Esteban E, Barthélémy P, Schmidinger M, Busch J, Valderrama BP, Charnley N, Schmitz M, Schumacher U, Leucht K, Foller S, Baretton G, Duran I, de Velasco G, Priou F, Maroto P, Albiges L; TITAN-RCC study group. Grimm MO, et al. Lancet Oncol. 2023 Nov;24(11):1252-1265. doi: 10.1016/S1470-2045(23)00449-7. Epub 2023 Oct 13. Lancet Oncol. 2023. PMID: 37844597 Clinical Trial.
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy.
Meacci E, Nachira D, Congedo MT, Ibrahim M, Pariscenti G, Petrella F, Casiraghi M, De Stefani A, Del Regno L, Peris K, Triumbari EKA, Schinzari G, Rossi E, Petracca-Ciavarella L, Vita ML, Chiappetta M, Siciliani A, Peritore V, Manitto M, Morelli L, Zanfrini E, Tabacco D, Calabrese G, Bardoni C, Evangelista J, Spaggiari L, Margaritora S. Meacci E, et al. Among authors: schinzari g. Cancers (Basel). 2023 Apr 25;15(9):2462. doi: 10.3390/cancers15092462. Cancers (Basel). 2023. PMID: 37173927 Free PMC article.
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
Chiloiro S, Giampietro A, Bianchi A, Menotti S, Angelini F, Tartaglione T, Antonini Cappellini GC, De Galitiis F, Rossi E, Schinzari G, Scoppola A, Pontecorvi A, De Marinis L, Fleseriu M. Chiloiro S, et al. Among authors: schinzari g. J Pers Med. 2023 Feb 26;13(3):415. doi: 10.3390/jpm13030415. J Pers Med. 2023. PMID: 36983597 Free PMC article.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
Anpalakhan S, Signori A, Cortellini A, Verzoni E, Giusti R, Aprile G, Ermacora P, Catino A, Pipitone S, Di Napoli M, Scotti V, Mazzoni F, Guglielmini PF, Veccia A, Maruzzo M, Schinzari G, Casadei C, Grossi F, Rizzo M, Montesarchio V, Verderame F, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Tondini CA, Camerini A, Banzi MC, Sorarù M, Zucali PA, Vignani F, Ricciardi S, Russo A, Cosenza A, Di Maio M, De Giorgi U, Pignata S, Giannarelli D, Pinto C, Buti S, Fornarini G, Rebuzzi SE, Rescigno P, Addeo A, Banna GL, Bersanelli M. Anpalakhan S, et al. Among authors: schinzari g. iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17. iScience. 2023. PMID: 37860695 Free PMC article.
Duodenal metastasis from a primary angiosarcoma of the colon.
Cammarota G, Schinzari G, Larocca LM, Gasbarrini G, Barone C. Cammarota G, et al. Among authors: schinzari g. Gastrointest Endosc. 2006 Feb;63(2):330; discussion 330. doi: 10.1016/j.gie.2005.06.062. Gastrointest Endosc. 2006. PMID: 16427950 No abstract available.
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients.
Basso M, Strippoli A, Orlandi A, Martini M, Calegari MA, Schinzari G, Di Salvatore M, Cenci T, Cassano A, Larocca LM, Barone C. Basso M, et al. Among authors: schinzari g. Br J Cancer. 2013 Jan 15;108(1):115-20. doi: 10.1038/bjc.2012.526. Epub 2012 Nov 22. Br J Cancer. 2013. PMID: 23175150 Free PMC article.
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?
Pantano F, Santoni M, Procopio G, Rizzo M, Iacovelli R, Porta C, Conti A, Lugini A, Milella M, Galli L, Ortega C, Guida FM, Silletta M, Schinzari G, Verzoni E, Modica D, Crucitti P, Rauco A, Felici A, Ballatore V, Cascinu S, Tonini G, Carteni G, Russo A, Santini D. Pantano F, et al. Among authors: schinzari g. PLoS One. 2015 Apr 17;10(4):e0120427. doi: 10.1371/journal.pone.0120427. eCollection 2015. PLoS One. 2015. PMID: 25885920 Free PMC article.
115 results